Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma

被引：72

作者：

Lemieux, B ^{[1
]}

Tartas, S ^{[1
]}

Traulle, C ^{[1
]}

Espinouse, D ^{[1
]}

Thieblemont, C ^{[1
]}

Bouafia, F ^{[1
]}

Alhusein, Q ^{[1
]}

Antal, D ^{[1
]}

Salles, G ^{[1
]}

Coiffier, B ^{[1
]}

机构：

[1] Univ Lyon 1, Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Haematol, F-69495 Pierre Benite, France

来源：

BONE MARROW TRANSPLANTATION | 2004年 / 33卷 / 09期

关键词：

non-Hodgkin's lymphoma; rituximab; autologous transplantation;

D O I：

10.1038/sj.bmt.1704467

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Rituximab, an anti-CD20 monoclonal antibody, is increasingly used in the treatment of B-cell non-Hodgkin's lymphoma. Late-onset neutropenia in relation to rituximab has been recently described. In this report, we present six cases occurring after stem cell transplantation and discuss the potential impact of this complication.

引用

页码：921 / 923

页数：3

共 50 条

[21] 90Y-Ibritumomab Tiuxetan as Consolidation Therapy After Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma [J].

Ria, Roberto ;

Musto, Pellegrino ;

Reale, Antonia ;

Guariglia, Roberto ;

Iodice, Giuseppe ;

Dammacco, Franco ;

Vacca, Angelo .

JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (06) :891-895

[22] Outcome after high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive B-cell non-Hodgkin's lymphoma [J].

Kriegsmann, Katharina ;

Rieger, Michael ;

Schwarzbich, Mark-Alexander ;

Sitter, Soeren ;

Kriegsmann, Mark ;

Bruckner, Thomas ;

Hensel, Manfred ;

Ho, Anthony Dick ;

Witzens-Harig, Mathias ;

Wuchter, Patrick .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) :12-20

[23] Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma [J].

Flinn, IW ;

O'Donnell, PV ;

Goodrich, A ;

Vogelsang, G ;

Abrams, R ;

Noga, S ;

Marcellus, D ;

Borowitz, M ;

Jones, R ;

Ambinder, RF .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) :628-632

[24] Disseminated Cryptococcosis in a Non-Hodgkin’s Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review [J].

Yuji Hirai ;

Yusuke Ainoda ;

Takayo Shoji ;

Takahiro Fujita ;

Kentaro Yoshinaga ;

Masayuki Shiseki ;

Naoki Mori ;

Masanao Teramura ;

Kyoichi Totsuka ;

Toshiko Motoji .

Mycopathologia, 2011, 172 :227-232

[25] Disseminated Cryptococcosis in a Non-Hodgkin's Lymphoma Patient with Late-Onset Neutropenia Following Rituximab-CHOP Chemotherapy: A Case Report and Literature Review [J].

Hirai, Yuji ;

Ainoda, Yusuke ;

Shoji, Takayo ;

Fujita, Takahiro ;

Yoshinaga, Kentaro ;

Shiseki, Masayuki ;

Mori, Naoki ;

Teramura, Masanao ;

Totsuka, Kyoichi ;

Motoji, Toshiko .

MYCOPATHOLOGIA, 2011, 172 (03) :227-232

[26] STEM CELL TRANSPLANTATION FOR NON-HODGKIN'S LYMPHOMA (NHL) [J].

De Souza, Carmino .

LEUKEMIA RESEARCH, 2017, 61 :S11-S12

[27] Mucosal melanoma following autologous stem cell transplantation for non-Hodgkin's lymphoma (NHL) [J].

BenYosef, R ;

Braverman, I ;

Saah, D ;

Nagler, R ;

Shohat, S ;

Or, R ;

Nagler, A .

BONE MARROW TRANSPLANTATION, 1996, 18 (05) :1017-1019

[28] Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma [J].

Arai, Yasuyuki ;

Yamashita, Kouhei ;

Mizugishi, Kiyomi ;

Nishikori, Momoko ;

Hishizawa, Masakatsu ;

Kondo, Tadakazu ;

Kitano, Toshiyuki ;

Kawabata, Hiroshi ;

Kadowaki, Norimitsu ;

Takaori-Kondo, Akifumi .

Hematology, 2015, 20 (04) :196-202

[29] Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma [J].

Michal Sieniawski ;

Oliver Staak ;

Jan-Peter Glossmann ;

Thorsten Reineke ;

Helena Scheuß ;

Volker Diehl ;

Andreas Engert ;

Andreas Josting .

Annals of Hematology, 2007, 86 :107-115

[30] Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma [J].

Sieniawski, Michal ;

Staak, Oliver ;

Glossmann, Jan-Peter ;

Reineke, Thorsten ;

Scheuss, Helena ;

Diehl, Volker ;

Engert, Andreas ;

Josting, Andreas .

ANNALS OF HEMATOLOGY, 2007, 86 (02) :107-115

← 1 2 3 4 5 →